Skip to content

13F-HR filed by BAILARD, INC.

BAILARD, INC. filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-10-18, with 528 holding rows worth $1,653,671,000.

Accession
0001085146-19-002584
Filed
2019-10-18
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 528 entries on the cover page, a total value of $1,653,671,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,653,671,000 with VALUE read as thousands by filing date, 13F file number 028-01707. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TITAN MACHY INC88830R101COM10,400$149,000thousands by filing date
OLD SECOND BANCORP INC680277100COMMON STOCK12,200$149,000thousands by filing date
TILLYS INC886885102CL A15,800$149,000thousands by filing date
MAYVILLE ENGINEERING CO INC578605107COMMON STOCK11,200$148,000thousands by filing date
Amplify Energy Corp03212B103COM23,500$145,000thousands by filing date
MESA AIR GROUP INC590479135COM NEW20,900$141,000thousands by filing date
SILVERCREST ASSET MANAGEME A828359109COMMON STOCK11,100$137,000thousands by filing date
SIENTRA INC82621J105COM20,800$135,000thousands by filing date
APYX MEDICAL CORPORATION03837C106COM18,922$128,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM11,000$126,000thousands by filing date
SILVERBOW RES INC82836G102COM13,030$126,000thousands by filing date
GENIE ENERGY LTD372284208CL B16,300$122,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM13,300$121,000thousands by filing date
IDT CORP448947507CL B NEW11,300$119,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock104,240$111,000thousands by filing date
ARDELYX INC039697107COM23,141$109,000thousands by filing date
NEOPHOTONICS CORP64051T100COM17,395$106,000thousands by filing date
PERCEPTRON INC71361F100COMMON STOCK19,100$92,000thousands by filing date
ASPEN AEROGELS INC04523Y105COMMON STOCK15,300$91,000thousands by filing date
CROWN CRAFTS INC228309100COM12,400$78,000thousands by filing date
ACCURAY INC DEL004397105COM27,400$76,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM22,800$76,000thousands by filing date
CUMBERLAND PHARMACEUTICALS I230770109COM11,816$70,000thousands by filing date
ARC DOCUMENT SOLUTIONS INC00191G103COM50,030$68,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM12,800$59,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK14,900$58,000thousands by filing date
BANCO BILBAO VIZCAYA ARGENTARI SPONSORED ADR05946K101ADR10,649$55,000thousands by filing date
FIVE PRIME THERAPEUTICS INC.33830X104Common Stock13,000$50,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-19-002584this filing2019-10-18acceptance time not in the bulk data set